Pages that link to "Q42978625"
Jump to navigation
Jump to search
The following pages link to A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures (Q42978625):
Displaying 50 items.
- Neutralizing antibody response to hepatitis C virus (Q27027484) (← links)
- Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus (Q27469355) (← links)
- Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization. (Q27469367) (← links)
- Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection (Q27469507) (← links)
- Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection (Q27469524) (← links)
- Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus (Q27469536) (← links)
- Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy (Q27469620) (← links)
- Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters (Q27469638) (← links)
- Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees (Q27469647) (← links)
- Replication of GB virus C (hepatitis G virus) in interferon-resistant Daudi cells (Q27469728) (← links)
- Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment (Q27469804) (← links)
- An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies (Q27469837) (← links)
- Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity (Q27469851) (← links)
- Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes (Q27469889) (← links)
- Production and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1 (Q27470002) (← links)
- Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome (Q27471683) (← links)
- Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles (Q27472891) (← links)
- Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein (Q27473461) (← links)
- Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus (Q27485325) (← links)
- Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a (Q27486521) (← links)
- Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C (Q27486537) (← links)
- Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees (Q27489101) (← links)
- Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles (Q27490271) (← links)
- In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes (Q27491029) (← links)
- The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies (Q29619723) (← links)
- Structure and functions of hepatitis C virus proteins: 15 years after. (Q30361273) (← links)
- HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation (Q30438047) (← links)
- Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. (Q30657711) (← links)
- Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. (Q30777430) (← links)
- Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus. (Q30823954) (← links)
- Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries (Q30828468) (← links)
- Protective immunity against hepatitis C: many shades of gray. (Q33759224) (← links)
- Immunopathogenesis of hepatitis C virus infection (Q33809427) (← links)
- Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models (Q33867634) (← links)
- Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro (Q33868489) (← links)
- Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites (Q33870023) (← links)
- Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues (Q33888820) (← links)
- Molecular biology of hepatitis C infection (Q33983949) (← links)
- Humoral immune response in acute hepatitis C virus infection (Q33989160) (← links)
- Immunopathogenesis of viral hepatitis (Q34005309) (← links)
- Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells (Q34112888) (← links)
- Human liver transplantation as a model to study hepatitis C virus pathogenesis (Q34197528) (← links)
- The molecular biology of hepatitis C virus. Genotypes and quasispecies (Q34210660) (← links)
- DNA vaccination: a potential weapon against infection and cancer. (Q34242413) (← links)
- Evidence for separation of HCV subtype 1a into two distinct clades. (Q34242504) (← links)
- Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma (Q34337134) (← links)
- In search of hepatitis C virus receptor(s). (Q34422731) (← links)
- Hepatitis C virus. The importance of viral heterogeneity. (Q34422738) (← links)
- The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development. (Q34481429) (← links)
- Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization (Q34863986) (← links)